- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.30 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x MN: MANGANESE (II) ION(Non-covalent)
- 24 x FMT: FORMIC ACID(Non-functional Binders)
FMT.3: 8 residues within 4Å:- Chain A: H.71, H.72, E.75
- Chain W: H.167, H.168, E.171
- Ligands: MN.1, MN.2
Ligand excluded by PLIPFMT.8: 8 residues within 4Å:- Chain B: H.71, H.72, E.75
- Chain V: H.167, H.168, E.171
- Ligands: MN.6, MN.7
Ligand excluded by PLIPFMT.13: 8 residues within 4Å:- Chain C: H.71, H.72, E.75
- Chain U: H.167, H.168, E.171
- Ligands: MN.11, MN.12
Ligand excluded by PLIPFMT.18: 8 residues within 4Å:- Chain D: H.71, H.72, E.75
- Chain X: H.167, H.168, E.171
- Ligands: MN.16, MN.17
Ligand excluded by PLIPFMT.23: 8 residues within 4Å:- Chain E: H.71, H.72, E.75
- Chain T: H.167, H.168, E.171
- Ligands: MN.21, MN.22
Ligand excluded by PLIPFMT.28: 8 residues within 4Å:- Chain F: H.71, H.72, E.75
- Chain Q: H.167, H.168, E.171
- Ligands: MN.26, MN.27
Ligand excluded by PLIPFMT.33: 8 residues within 4Å:- Chain G: H.71, H.72, E.75
- Chain R: H.167, H.168, E.171
- Ligands: MN.31, MN.32
Ligand excluded by PLIPFMT.38: 8 residues within 4Å:- Chain H: H.71, H.72, E.75
- Chain S: H.167, H.168, E.171
- Ligands: MN.36, MN.37
Ligand excluded by PLIPFMT.43: 8 residues within 4Å:- Chain I: H.71, H.72, E.75
- Chain M: H.167, H.168, E.171
- Ligands: MN.41, MN.42
Ligand excluded by PLIPFMT.48: 8 residues within 4Å:- Chain J: H.71, H.72, E.75
- Chain P: H.167, H.168, E.171
- Ligands: MN.46, MN.47
Ligand excluded by PLIPFMT.53: 8 residues within 4Å:- Chain K: H.71, H.72, E.75
- Chain O: H.167, H.168, E.171
- Ligands: MN.51, MN.52
Ligand excluded by PLIPFMT.58: 8 residues within 4Å:- Chain L: H.71, H.72, E.75
- Chain N: H.167, H.168, E.171
- Ligands: MN.56, MN.57
Ligand excluded by PLIPFMT.63: 8 residues within 4Å:- Chain K: H.167, H.168, E.171
- Chain M: H.71, H.72, E.75
- Ligands: MN.61, MN.62
Ligand excluded by PLIPFMT.68: 8 residues within 4Å:- Chain J: H.167, H.168, E.171
- Chain N: H.71, H.72, E.75
- Ligands: MN.66, MN.67
Ligand excluded by PLIPFMT.73: 8 residues within 4Å:- Chain I: H.167, H.168, E.171
- Chain O: H.71, H.72, E.75
- Ligands: MN.71, MN.72
Ligand excluded by PLIPFMT.78: 8 residues within 4Å:- Chain L: H.167, H.168, E.171
- Chain P: H.71, H.72, E.75
- Ligands: MN.76, MN.77
Ligand excluded by PLIPFMT.83: 8 residues within 4Å:- Chain H: H.167, H.168, E.171
- Chain Q: H.71, H.72, E.75
- Ligands: MN.81, MN.82
Ligand excluded by PLIPFMT.88: 8 residues within 4Å:- Chain E: H.167, H.168, E.171
- Chain R: H.71, H.72, E.75
- Ligands: MN.86, MN.87
Ligand excluded by PLIPFMT.93: 8 residues within 4Å:- Chain F: H.167, H.168, E.171
- Chain S: H.71, H.72, E.75
- Ligands: MN.91, MN.92
Ligand excluded by PLIPFMT.98: 8 residues within 4Å:- Chain G: H.167, H.168, E.171
- Chain T: H.71, H.72, E.75
- Ligands: MN.96, MN.97
Ligand excluded by PLIPFMT.103: 8 residues within 4Å:- Chain A: H.167, H.168, E.171
- Chain U: H.71, H.72, E.75
- Ligands: MN.101, MN.102
Ligand excluded by PLIPFMT.108: 8 residues within 4Å:- Chain D: H.167, H.168, E.171
- Chain V: H.71, H.72, E.75
- Ligands: MN.106, MN.107
Ligand excluded by PLIPFMT.113: 8 residues within 4Å:- Chain C: H.167, H.168, E.171
- Chain W: H.71, H.72, E.75
- Ligands: MN.111, MN.112
Ligand excluded by PLIPFMT.118: 8 residues within 4Å:- Chain B: H.167, H.168, E.171
- Chain X: H.71, H.72, E.75
- Ligands: MN.116, MN.117
Ligand excluded by PLIP- 24 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
TRS.4: 11 residues within 4Å:- Chain A: T.102, H.111, L.161
- Chain H: T.102, H.111, L.161
- Chain K: T.102, H.111, L.161
- Ligands: TRS.39, TRS.54
Ligand excluded by PLIPTRS.9: 11 residues within 4Å:- Chain B: T.102, H.111, L.161
- Chain F: T.102, H.111, L.161
- Chain J: T.102, H.111, L.161
- Ligands: TRS.29, TRS.49
Ligand excluded by PLIPTRS.14: 11 residues within 4Å:- Chain C: T.102, H.111, L.161
- Chain E: T.102, H.111, L.161
- Chain L: T.102, H.111, L.161
- Ligands: TRS.24, TRS.59
Ligand excluded by PLIPTRS.19: 11 residues within 4Å:- Chain D: T.102, H.111, L.161
- Chain G: T.102, H.111, L.161
- Chain I: T.102, H.111, L.161
- Ligands: TRS.34, TRS.44
Ligand excluded by PLIPTRS.24: 11 residues within 4Å:- Chain C: T.102, H.111, L.161
- Chain E: T.102, H.111, L.161
- Chain L: T.102, H.111, L.161
- Ligands: TRS.14, TRS.59
Ligand excluded by PLIPTRS.29: 11 residues within 4Å:- Chain B: T.102, H.111, L.161
- Chain F: T.102, H.111, L.161
- Chain J: T.102, H.111, L.161
- Ligands: TRS.9, TRS.49
Ligand excluded by PLIPTRS.34: 11 residues within 4Å:- Chain D: T.102, H.111, L.161
- Chain G: T.102, H.111, L.161
- Chain I: T.102, H.111, L.161
- Ligands: TRS.19, TRS.44
Ligand excluded by PLIPTRS.39: 11 residues within 4Å:- Chain A: T.102, H.111, L.161
- Chain H: T.102, H.111, L.161
- Chain K: T.102, H.111, L.161
- Ligands: TRS.4, TRS.54
Ligand excluded by PLIPTRS.44: 11 residues within 4Å:- Chain D: T.102, H.111, L.161
- Chain G: T.102, H.111, L.161
- Chain I: T.102, H.111, L.161
- Ligands: TRS.19, TRS.34
Ligand excluded by PLIPTRS.49: 11 residues within 4Å:- Chain B: T.102, H.111, L.161
- Chain F: T.102, H.111, L.161
- Chain J: T.102, H.111, L.161
- Ligands: TRS.9, TRS.29
Ligand excluded by PLIPTRS.54: 11 residues within 4Å:- Chain A: T.102, H.111, L.161
- Chain H: T.102, H.111, L.161
- Chain K: T.102, H.111, L.161
- Ligands: TRS.4, TRS.39
Ligand excluded by PLIPTRS.59: 11 residues within 4Å:- Chain C: T.102, H.111, L.161
- Chain E: T.102, H.111, L.161
- Chain L: T.102, H.111, L.161
- Ligands: TRS.14, TRS.24
Ligand excluded by PLIPTRS.64: 11 residues within 4Å:- Chain M: T.102, H.111, L.161
- Chain T: T.102, H.111, L.161
- Chain W: T.102, H.111, L.161
- Ligands: TRS.99, TRS.114
Ligand excluded by PLIPTRS.69: 11 residues within 4Å:- Chain N: T.102, H.111, L.161
- Chain R: T.102, H.111, L.161
- Chain V: T.102, H.111, L.161
- Ligands: TRS.89, TRS.109
Ligand excluded by PLIPTRS.74: 11 residues within 4Å:- Chain O: T.102, H.111, L.161
- Chain Q: T.102, H.111, L.161
- Chain X: T.102, H.111, L.161
- Ligands: TRS.84, TRS.119
Ligand excluded by PLIPTRS.79: 11 residues within 4Å:- Chain P: T.102, H.111, L.161
- Chain S: T.102, H.111, L.161
- Chain U: T.102, H.111, L.161
- Ligands: TRS.94, TRS.104
Ligand excluded by PLIPTRS.84: 11 residues within 4Å:- Chain O: T.102, H.111, L.161
- Chain Q: T.102, H.111, L.161
- Chain X: T.102, H.111, L.161
- Ligands: TRS.74, TRS.119
Ligand excluded by PLIPTRS.89: 11 residues within 4Å:- Chain N: T.102, H.111, L.161
- Chain R: T.102, H.111, L.161
- Chain V: T.102, H.111, L.161
- Ligands: TRS.69, TRS.109
Ligand excluded by PLIPTRS.94: 11 residues within 4Å:- Chain P: T.102, H.111, L.161
- Chain S: T.102, H.111, L.161
- Chain U: T.102, H.111, L.161
- Ligands: TRS.79, TRS.104
Ligand excluded by PLIPTRS.99: 11 residues within 4Å:- Chain M: T.102, H.111, L.161
- Chain T: T.102, H.111, L.161
- Chain W: T.102, H.111, L.161
- Ligands: TRS.64, TRS.114
Ligand excluded by PLIPTRS.104: 11 residues within 4Å:- Chain P: T.102, H.111, L.161
- Chain S: T.102, H.111, L.161
- Chain U: T.102, H.111, L.161
- Ligands: TRS.79, TRS.94
Ligand excluded by PLIPTRS.109: 11 residues within 4Å:- Chain N: T.102, H.111, L.161
- Chain R: T.102, H.111, L.161
- Chain V: T.102, H.111, L.161
- Ligands: TRS.69, TRS.89
Ligand excluded by PLIPTRS.114: 11 residues within 4Å:- Chain M: T.102, H.111, L.161
- Chain T: T.102, H.111, L.161
- Chain W: T.102, H.111, L.161
- Ligands: TRS.64, TRS.99
Ligand excluded by PLIPTRS.119: 11 residues within 4Å:- Chain O: T.102, H.111, L.161
- Chain Q: T.102, H.111, L.161
- Chain X: T.102, H.111, L.161
- Ligands: TRS.74, TRS.84
Ligand excluded by PLIP- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 5 residues within 4Å:- Chain A: R.159
- Chain H: R.159
- Chain K: R.159
- Ligands: CL.40, CL.55
Ligand excluded by PLIPCL.10: 5 residues within 4Å:- Chain B: R.159
- Chain F: R.159
- Chain J: R.159
- Ligands: CL.30, CL.50
Ligand excluded by PLIPCL.15: 5 residues within 4Å:- Chain C: R.159
- Chain E: R.159
- Chain L: R.159
- Ligands: CL.25, CL.60
Ligand excluded by PLIPCL.20: 5 residues within 4Å:- Chain D: R.159
- Chain G: R.159
- Chain I: R.159
- Ligands: CL.35, CL.45
Ligand excluded by PLIPCL.25: 5 residues within 4Å:- Chain C: R.159
- Chain E: R.159
- Chain L: R.159
- Ligands: CL.15, CL.60
Ligand excluded by PLIPCL.30: 5 residues within 4Å:- Chain B: R.159
- Chain F: R.159
- Chain J: R.159
- Ligands: CL.10, CL.50
Ligand excluded by PLIPCL.35: 5 residues within 4Å:- Chain D: R.159
- Chain G: R.159
- Chain I: R.159
- Ligands: CL.20, CL.45
Ligand excluded by PLIPCL.40: 5 residues within 4Å:- Chain A: R.159
- Chain H: R.159
- Chain K: R.159
- Ligands: CL.5, CL.55
Ligand excluded by PLIPCL.45: 5 residues within 4Å:- Chain D: R.159
- Chain G: R.159
- Chain I: R.159
- Ligands: CL.20, CL.35
Ligand excluded by PLIPCL.50: 5 residues within 4Å:- Chain B: R.159
- Chain F: R.159
- Chain J: R.159
- Ligands: CL.10, CL.30
Ligand excluded by PLIPCL.55: 5 residues within 4Å:- Chain A: R.159
- Chain H: R.159
- Chain K: R.159
- Ligands: CL.5, CL.40
Ligand excluded by PLIPCL.60: 5 residues within 4Å:- Chain C: R.159
- Chain E: R.159
- Chain L: R.159
- Ligands: CL.15, CL.25
Ligand excluded by PLIPCL.65: 5 residues within 4Å:- Chain M: R.159
- Chain T: R.159
- Chain W: R.159
- Ligands: CL.100, CL.115
Ligand excluded by PLIPCL.70: 5 residues within 4Å:- Chain N: R.159
- Chain R: R.159
- Chain V: R.159
- Ligands: CL.90, CL.110
Ligand excluded by PLIPCL.75: 5 residues within 4Å:- Chain O: R.159
- Chain Q: R.159
- Chain X: R.159
- Ligands: CL.85, CL.120
Ligand excluded by PLIPCL.80: 5 residues within 4Å:- Chain P: R.159
- Chain S: R.159
- Chain U: R.159
- Ligands: CL.95, CL.105
Ligand excluded by PLIPCL.85: 5 residues within 4Å:- Chain O: R.159
- Chain Q: R.159
- Chain X: R.159
- Ligands: CL.75, CL.120
Ligand excluded by PLIPCL.90: 5 residues within 4Å:- Chain N: R.159
- Chain R: R.159
- Chain V: R.159
- Ligands: CL.70, CL.110
Ligand excluded by PLIPCL.95: 5 residues within 4Å:- Chain P: R.159
- Chain S: R.159
- Chain U: R.159
- Ligands: CL.80, CL.105
Ligand excluded by PLIPCL.100: 5 residues within 4Å:- Chain M: R.159
- Chain T: R.159
- Chain W: R.159
- Ligands: CL.65, CL.115
Ligand excluded by PLIPCL.105: 5 residues within 4Å:- Chain P: R.159
- Chain S: R.159
- Chain U: R.159
- Ligands: CL.80, CL.95
Ligand excluded by PLIPCL.110: 5 residues within 4Å:- Chain N: R.159
- Chain R: R.159
- Chain V: R.159
- Ligands: CL.70, CL.90
Ligand excluded by PLIPCL.115: 5 residues within 4Å:- Chain M: R.159
- Chain T: R.159
- Chain W: R.159
- Ligands: CL.65, CL.100
Ligand excluded by PLIPCL.120: 5 residues within 4Å:- Chain O: R.159
- Chain Q: R.159
- Chain X: R.159
- Ligands: CL.75, CL.85
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bisson, C. et al., Crystal Structures Reveal that the Reaction Mechanism of Imidazoleglycerol-Phosphate Dehydratase Is Controlled by Switching Mn(II) Coordination. Structure (2015)
- Release Date
- 2015-06-24
- Peptides
- Imidazoleglycerol-phosphate dehydratase 2, chloroplastic: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.30 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x MN: MANGANESE (II) ION(Non-covalent)
- 24 x FMT: FORMIC ACID(Non-functional Binders)
- 24 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bisson, C. et al., Crystal Structures Reveal that the Reaction Mechanism of Imidazoleglycerol-Phosphate Dehydratase Is Controlled by Switching Mn(II) Coordination. Structure (2015)
- Release Date
- 2015-06-24
- Peptides
- Imidazoleglycerol-phosphate dehydratase 2, chloroplastic: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A